MED12 overexpression is a frequent event in castration-resistant prostate cancer

Zaki Shaikhibrahim, Anne Offermann, Martin Braun, Roopika Menon, Isabella Syring, Michael Nowak, Rebecca Halbach, Wenzel Vogel, Christian Ruiz, Tobias Zellweger, Cyrill A. Rentsch, Maria Svensson, Ove Andren, Lukas Bubendorf, Saskia Biskup, Stefan Duensing, Jutta Kirfel, Sven Perner*

*Corresponding author for this work
19 Citations (Scopus)

Fingerprint

Dive into the research topics of 'MED12 overexpression is a frequent event in castration-resistant prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences